Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
2.510
-0.160 (-5.99%)
At close: Apr 1, 2025, 4:00 PM
2.529
+0.019 (0.76%)
After-hours: Apr 1, 2025, 4:23 PM EDT
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,593,080
Market Cap
87.06M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ACHV News
- 21 days ago - Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program - GlobeNewsWire
- 25 days ago - Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference - GlobeNewsWire
- 26 days ago - Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - GlobeNewsWire
- 7 weeks ago - Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference - GlobeNewsWire
- 7 weeks ago - Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors - GlobeNewsWire
- 3 months ago - Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission - GlobeNewsWire